| Financial Year |
March 31 2023 |
| Monetary Funds |
22,573,953,464.93 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
203,735,805.53 |
| Accounts Receivable |
1,693,325,395.69 |
| Advances to Suppliers |
901,152,358.85 |
| Other Receivables |
1,052,067,375.94 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,608,000.00 |
| Inventories |
9,656,881,462.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
191,262,030.30 |
| Other Current Assets |
576,197,020.56 |
| Total Current Assets |
44,504,502,010.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
120,055,635.43 |
| Long-term Equity Investment |
5,077,095,010.37 |
| Investment Properties |
77,382,105.31 |
| Fixed Assetes |
9,286,976,988.97 |
| Under-construction Projects |
1,979,553,188.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,510,335,986.84 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
79,400.00 |
| Deferred Income Tax Assets |
2,184,661,270.91 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
21,898,725,418.18 |
| Total Assets |
66,403,227,428.58 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
10,596,140,866.49 |
| Accounts Payable |
17,869,835,702.92 |
| Accounts Received In Advance |
754,877.92 |
| Employee Compensation Payable |
382,777,334.66 |
| Taxes Payable |
143,469,082.55 |
| Interest Payable |
-- |
| Dividend Payable |
171,500.02 |
| Other payables |
5,946,650,974.99 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
32,371,037.13 |
| Other Current Liabilities |
218,267,096.28 |
| Sub-Total of Current Liabilities |
37,532,411,307.10 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
842,096,864.17 |
| Deferred Income Tax Liabilities |
416,040,056.51 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,084,387,020.72 |
| Total Liabilities |
42,616,798,327.82 |
| Paid-In Capital(Or Share Stock) |
4,651,242,220.00 |
| Capital Surplus |
10,451,498,282.35 |
| Surplus Reserve |
3,058,249,602.44 |
| LESS:Treasury Stock |
263,320,811.94 |
| Undistributed Profits |
5,522,724,812.31 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
23,786,429,100.76 |
| Owner's Equity（Stockholder's Equity） |
23,786,429,100.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
66,403,227,428.58 |
